Stereotaxis (STXS) News Today $2.19 -0.10 (-4.37%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$2.19 +0.00 (+0.23%) As of 02/21/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Stock Market Sleeps On Stereotaxis MAGiC CE MarkFebruary 14, 2025 | seekingalpha.comLegato Capital Management LLC Cuts Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS)Legato Capital Management LLC trimmed its position in Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) by 23.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 360,291 shares of the company's stocFebruary 14, 2025 | marketbeat.comStereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025February 3, 2025 | globenewswire.comPrecio de las acciones, noticias, cotización e historial de Stereotaxis, Inc. (STXS) - Yahoo FinanzasFebruary 2, 2025 | finance.yahoo.comTD Cowen Keeps Their Buy Rating on Stereotaxis (STXS)January 31, 2025 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Stereotaxis (STXS)January 31, 2025 | markets.businessinsider.comStereotaxis Announces First GenesisX Robotic System OrderJanuary 30, 2025 | globenewswire.comStereotaxis receives CE Mark approval for MAGiC ablation catheterJanuary 28, 2025 | markets.businessinsider.comLake Street Remains a Buy on Stereotaxis (STXS)January 28, 2025 | markets.businessinsider.comStereotaxis, Inc.: Stereotaxis Receives CE Mark Approval for the MAGiC Ablation CatheterJanuary 27, 2025 | finanznachrichten.deStereotaxis Hikes on Winning European ApprovalJanuary 27, 2025 | baystreet.caStereotaxis Receives CE Mark Approval for the MAGiC Ablation CatheterJanuary 27, 2025 | globenewswire.comTraynor Capital Management Inc. Acquires Shares of 160,509 Stereotaxis, Inc. (NYSEAMERICAN:STXS)Traynor Capital Management Inc. bought a new position in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 160,509 shares of the company's stock, valuedJanuary 24, 2025 | marketbeat.comStereotaxis Positioned for 2025 Growth: Buy Rating Backed by Strong Pipeline, Regulatory Approvals, and Solid FinancialsJanuary 17, 2025 | markets.businessinsider.comStereotaxis announces Genesis RMN use by Oulu University HospitalJanuary 14, 2025 | markets.businessinsider.comOulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic TechnologyJanuary 14, 2025 | globenewswire.comWhy Stereotaxis (STXS) Is Among the Cheap Robotics Stocks to Invest In Now?January 13, 2025 | msn.comStereotaxis (NYSEAMERICAN:STXS) Shares Down 2.2% - Here's WhyStereotaxis (NYSEAMERICAN:STXS) Stock Price Down 2.2% - Here's What HappenedDecember 13, 2024 | marketbeat.comStereotaxis, Medtech announce catheter approved by China’s NMPADecember 9, 2024 | markets.businessinsider.comStereotaxis’s Strategic Advancements and Chinese Market Potential Drive Buy RatingDecember 9, 2024 | markets.businessinsider.comMagbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPADecember 9, 2024 | finance.yahoo.comMagbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPADecember 9, 2024 | globenewswire.comStereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical SystemsDecember 2, 2024 | finance.yahoo.comStereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical SystemsDecember 2, 2024 | globenewswire.comStereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025December 2, 2024 | seekingalpha.comStereotaxis to Participate in Piper Sandler 36th Annual Healthcare ConferenceNovember 26, 2024 | globenewswire.comStereotaxis, Inc.: Stereotaxis Genesis Robotic System Achieves Regulatory Approval in ChinaNovember 25, 2024 | finanznachrichten.deStrategic Partnerships and Regulatory Advancements Propel Stereotaxis to Buy RatingNovember 25, 2024 | markets.businessinsider.comStereotaxis Genesis Robotic System Achieves Regulatory Approval in ChinaNovember 25, 2024 | globenewswire.comHospital Da Luz is the First in Portugal to Adopt Genesis Robotic SystemNovember 20, 2024 | globenewswire.comFY2024 EPS Estimate for Stereotaxis Decreased by AnalystStereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) - Roth Capital reduced their FY2024 earnings estimates for Stereotaxis in a research report issued to clients and investors on Tuesday, November 12th. Roth Capital analyst J. Wittes now expects that the company will earn ($0.24) per share for thNovember 15, 2024 | marketbeat.comLake Street Sticks to Its Buy Rating for Stereotaxis (STXS)November 13, 2024 | markets.businessinsider.comBullish Outlook on Stereotaxis: Strong Revenue Growth and Promising PipelineNovember 13, 2024 | markets.businessinsider.comPiper Sandler Releases a Buy Rating on Stereotaxis (STXS)November 13, 2024 | markets.businessinsider.comStereotaxis, Inc. (AMEX:STXS) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comStereotaxis, Inc. (STXS) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | seekingalpha.comStereotaxis Reports 2024 Third Quarter Financial ResultsNovember 11, 2024 | globenewswire.comStereotaxis Q3 2024 Earnings PreviewNovember 10, 2024 | msn.comStereotaxis Earnings PreviewNovember 9, 2024 | benzinga.comStereotaxis (AMEX:STXS) Stock Quotes, Forecast and News SummaryNovember 9, 2024 | benzinga.comStereotaxis Inc (STXS) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 8, 2024 | finance.yahoo.comUniversity of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic TechnologyNovember 6, 2024 | finance.yahoo.comStereotaxis’ technology to be featured at SCRN Annual MeetingOctober 22, 2024 | markets.businessinsider.comStereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic NavigationOctober 21, 2024 | globenewswire.comStereotaxis to Present at Upcoming Investor ConferencesSeptember 9, 2024 | globenewswire.comStereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX CongressSeptember 3, 2024 | markets.businessinsider.comStereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX CongressSeptember 3, 2024 | globenewswire.comStereotaxis Receives CE Mark For GenesisX, Nears MAGiC ApprovalAugust 25, 2024 | seekingalpha.comStereotaxis, Inc. (NYSEAMERICAN:STXS) Director Paul J. Isaac Purchases 8,095 SharesAugust 21, 2024 | insidertrades.comStereotaxis, Inc. (NYSEAMERICAN:STXS) Director Buys $15,380.50 in StockStereotaxis, Inc. (NYSEAMERICAN:STXS - Get Free Report) Director Paul J. Isaac bought 8,095 shares of the company's stock in a transaction dated Thursday, August 15th. The shares were acquired at an average cost of $1.90 per share, with a total value of $15,380.50. Following the acquisition, the director now directly owns 2,766,814 shares of the company's stock, valued at $5,256,946.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.August 20, 2024 | marketbeat.com Get Stereotaxis News Delivered to You Automatically Sign up to receive the latest news and ratings for STXS and its competitors with MarketBeat's FREE daily newsletter. Email Address STXS Media Mentions By Week STXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STXS News Sentiment▼0.000.60▲Average Medical News Sentiment STXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STXS Articles This Week▼02▲STXS Articles Average Week Get Stereotaxis News Delivered to You Automatically Sign up to receive the latest news and ratings for STXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AXGN News Today CBLL News Today IRMD News Today AVNS News Today SIBN News Today TMCI News Today KIDS News Today DCTH News Today CLPT News Today WEDXF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:STXS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stereotaxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stereotaxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STXS Stock Alerts